Table 5.
Subgroup analysis in association between cancer stigma and global health status/quality of life
| No stigma | Stigma | p-value | No stigma vs. stigma Coef (95% CI) | ||
|---|---|---|---|---|---|
|
| |||||
| Model 1a) | Model 2b) | ||||
| Disease characteristics (n = 73) | |||||
| Borderline | 83.33 (11.79) | 72.62 (9.27) | 0.13 | –7.80 (–32.05, 16.45) | –6.49 (–30.07, 17.09) |
| Cancer | 77.94 (17.51) | 60.12 (22.49) | < 0.01 | –19.23 (–28.98, –9.47) | –13.25 (–23.62, –2.88) |
| Stage (n = 62) | |||||
| Early stage | 71.15 (20.59) | 70.83 (25.00) | 0.98 | –3.06 (–28.22, 22.10) | 5.60 (–20.03, 31.23) |
| Advanced stage | 82.14 (14.26) | 58.33 (22.12) | < 0.01 | –22.58 (–34.61, –10.56) | –16.20 (–29.15, –3.23) |
| Type of cancer (n = 62) | |||||
| Others cancer | 78.47 (19.65) | 59.90 (23.22) | < 0.01 | –23.18 (–36.20, –10.17) | –18.33 (–31.74, –4.92) |
| Pancreatic cancer | 76.67 (11.65) | 60.42 (22.51) | 0.05 | –10.89 (–28.37, 6.59) | –3.25 (–21.46, 14.95) |
| Type of surgery (n = 62) | |||||
| No PD | 83.33 (13.82) | 60.61 (21.11) | 0.01 | –25.98 (–44.34, –7.61) | –21.40 (–39.92, –2.87) |
| PD | 76.00 (18.52) | 59.80 (23.98) | 0.01 | –16.08 (–28.53, –3.62) | –8.78 (–22.22, 4.66) |
| Adjuvant chemotherapy (n = 62) | |||||
| No | 74.44 (21.24) | 56.25 (17.68) | 0.05 | –27.29 (–45.70, –8.89) | –18.29 (–38.29, 1.71) |
| Yes | 80.70 (13.90) | 61.67 (24.39) | < 0.01 | –14.57 (–27.88, –1.27) | –10.46 (–24.12, 3.20) |
Values are presented as score (standard deviation).
Coef, coefficient; CI, confidence interval; PD, pancreaticoduodenectomy: including pylorus preserving pancreaticoduodenectomy, pylorus resecting pancreaticoduodenectomy, Whipple’s operation.
a)Model 1: Adjusted for age and sex. b)Model 2: Further adjusted for pain, diarrhea, nausea, and constipation.